(PBI) Pitney Bowes - Overview
Stock: Postage Meters, Mailing Software, Parcel Shipping, Presort Services, Financing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.03% |
| Yield on Cost 5y | 3.92% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 94.6% |
| Payout Ratio | 33.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 52.4% |
| Relative Tail Risk | -20.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.72 |
| Alpha | 9.74 |
| Character TTM | |
|---|---|
| Beta | 1.047 |
| Beta Downside | 1.390 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.17% |
| CAGR/Max DD | 1.14 |
Description: PBI Pitney Bowes January 14, 2026
Pitney Bowes Inc. (NYSE:PBI) is a technology-focused provider of SaaS shipping, mailing, and financial-services solutions for a broad client base that includes small businesses, large enterprises, and government agencies. The company operates through two segments: SendTech Solutions, which delivers physical and digital mailing and parcel-tracking technology, equipment financing, and related services; and Presort Services, which offers mail-sortation and discount-qualification services for first-class, marketing, and bulk printed mail.
Recent data (FY 2023) shows the SendTech Solutions segment generated roughly $1.2 billion in revenue, with subscription-based SaaS contracts now representing about 30 % of total sales-a trend consistent with the broader shift toward recurring-revenue models in the office-services sector. The business is sensitive to e-commerce volume growth (estimated 8-10 % YoY) and to postal-rate inflation, both of which can boost demand for integrated shipping solutions but also pressure margin if cost pass-through lags. Additionally, the company’s cash-flow conversion has improved to $0.45 per share, reflecting tighter working-capital management amid a tighter credit environment.
For a deeper, data-driven view of PBI’s valuation dynamics, you may find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 75.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.17 > 1.0 |
| NWC/Revenue: -14.09% < 20% (prev -9.74%; Δ -4.35% < -1%) |
| CFO/TA 0.09 > 3% & CFO 296.0m > Net Income 75.0m |
| Net Debt (1.90b) to EBITDA (323.4m): 5.89 < 3 |
| Current Ratio: 0.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (181.0m) vs 12m ago -1.54% < -2% |
| Gross Margin: 53.78% > 18% (prev 0.52%; Δ 5326 % > 0.5%) |
| Asset Turnover: 55.95% > 50% (prev 55.84%; Δ 0.11% > 0%) |
| Interest Coverage Ratio: 2.06 > 6 (EBITDA TTM 323.4m / Interest Expense TTM 102.0m) |
Altman Z'' 3.10
| A: -0.08 (Total Current Assets 1.15b - Total Current Liabilities 1.42b) / Total Assets 3.26b |
| B: 0.82 (Retained Earnings 2.66b / Total Assets 3.26b) |
| C: 0.06 (EBIT TTM 210.3m / Avg Total Assets 3.45b) |
| D: 0.55 (Book Value of Equity 2.16b / Total Liabilities 3.92b) |
| Altman-Z'' Score: 3.10 = A |
Beneish M -3.15
| DSRI: 0.95 (Receivables 663.6m/739.2m, Revenue 1.93b/2.04b) |
| GMI: 0.96 (GM 53.78% / 51.67%) |
| AQI: 1.11 (AQ_t 0.55 / AQ_t-1 0.50) |
| SGI: 0.95 (Revenue 1.93b / 2.04b) |
| TATA: -0.07 (NI 75.0m - CFO 296.0m) / TA 3.26b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of PBI shares?
Over the past week, the price has changed by +3.36%, over one month by +6.31%, over three months by +16.16% and over the past year by +28.25%.
Is PBI a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13 | 20.6% |
| Analysts Target Price | 13 | 20.6% |
| ValueRay Target Price | 13 | 20.1% |
PBI Fundamental Data Overview February 03, 2026
P/E Forward = 9.0744
P/S = 0.9385
P/B = 9.5693
P/EG = 0.6048
Revenue TTM = 1.93b USD
EBIT TTM = 210.3m USD
EBITDA TTM = 323.4m USD
Long Term Debt = 2.09b USD (from longTermDebt, last quarter)
Short Term Debt = 43.2m USD (from shortTermDebt, last quarter)
Debt = 2.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.90b USD (from netDebt column, last quarter)
Enterprise Value = 3.72b USD (1.81b + Debt 2.23b - CCE 321.0m)
Interest Coverage Ratio = 2.06 (Ebit TTM 210.3m / Interest Expense TTM 102.0m)
EV/FCF = 16.31x (Enterprise Value 3.72b / FCF TTM 227.8m)
FCF Yield = 6.13% (FCF TTM 227.8m / Enterprise Value 3.72b)
FCF Margin = 11.80% (FCF TTM 227.8m / Revenue TTM 1.93b)
Net Margin = 3.88% (Net Income TTM 75.0m / Revenue TTM 1.93b)
Gross Margin = 53.78% ((Revenue TTM 1.93b - Cost of Revenue TTM 892.6m) / Revenue TTM)
Gross Margin QoQ = 53.14% (prev 53.59%)
Tobins Q-Ratio = 1.14 (Enterprise Value 3.72b / Total Assets 3.26b)
Interest Expense / Debt = 1.17% (Interest Expense 26.1m / Debt 2.23b)
Taxrate = 23.75% (16.2m / 68.1m)
NOPAT = 160.4m (EBIT 210.3m * (1 - 23.75%))
Current Ratio = 0.81 (Total Current Assets 1.15b / Total Current Liabilities 1.42b)
Debt / Equity = -3.36 (negative equity) (Debt 2.23b / totalStockholderEquity, last quarter -661.5m)
Debt / EBITDA = 5.89 (Net Debt 1.90b / EBITDA 323.4m)
Debt / FCF = 8.36 (Net Debt 1.90b / FCF TTM 227.8m)
Total Stockholder Equity = -578.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.17% (Net Income 75.0m / Total Assets 3.26b)
RoE = -12.97% (negative equity) (Net Income TTM 75.0m / Total Stockholder Equity -578.2m)
RoCE = 13.93% (EBIT 210.3m / Capital Employed (Equity -578.2m + L.T.Debt 2.09b))
RoIC = 11.62% (NOPAT 160.4m / Invested Capital 1.38b)
WACC = 4.88% (E(1.81b)/V(4.04b) * Re(9.77%) + D(2.23b)/V(4.04b) * Rd(1.17%) * (1-Tc(0.24)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.31%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈178.0m ; Y1≈116.8m ; Y5≈53.3m
Fair Price DCF = N/A (negative equity: EV 1.70b - Net Debt 1.90b = -206.0m; debt exceeds intrinsic value)
EPS Correlation: 70.51 | EPS CAGR: 54.95% | SUE: -0.15 | # QB: 0
Revenue Correlation: -92.25 | Revenue CAGR: -18.36% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=+0.028 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=1.45 | Chg30d=+0.060 | Revisions Net=+1 | Growth EPS=+9.9% | Growth Revenue=-2.4%